The Patent Finder

Intronn, Inc.

Also on record
Records under this name other than patents Intronn, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Intronn, Inc.

PatentTitleStatus Expires Confidence
US 6,929,907Methods and compositions for determining the purity of chemically synthesized nucleic acids
Formerly held
Term ended
Term ended Jan 20, 2020 · From the USPTO record
Term endedTerm ended Jan 20, 2020From the USPTO record
US 8,053,232Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing
Formerly held
Lapsed on the fee record
Ended Nov 8, 2019 · From the USPTO record
Lapsed on the fee recordEnded Nov 8, 2019From the USPTO record
US 7,968,334Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
Formerly held
Lapsed on the fee record
Ended Jun 28, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jun 28, 2019From the USPTO record
US 7,879,321Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production
Formerly held
Lapsed on the fee record
Ended Feb 1, 2019 · From the USPTO record
Lapsed on the fee recordEnded Feb 1, 2019From the USPTO record
US 7,871,795Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins
Formerly held
Lapsed on the fee record
Ended Jan 18, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jan 18, 2019From the USPTO record
US 8,883,753Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
Formerly held
Lapsed on the fee record
Ended Nov 11, 2018 · From the USPTO record
Lapsed on the fee recordEnded Nov 11, 2018From the USPTO record
US 6,280,978Methods and compositions for use in spliceosome mediated RNA trans-splicing
Formerly held
Term ended
Term ended Sep 23, 2018 · From the USPTO record
Term endedTerm ended Sep 23, 2018From the USPTO record
US 7,094,399Use of spliceosome mediated RNA trans-splicing to confer cell selective replication to adenoviruses
Formerly held
Lapsed on the fee record
Ended Aug 22, 2018 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2018From the USPTO record
US 6,083,702Methods and compositions for use in spliceosome mediated RNA trans-splicing
Formerly held
Term ended
Term ended Aug 13, 2018 · From the USPTO record
Term endedTerm ended Aug 13, 2018From the USPTO record
US 6,013,487Chimeric RNA molecules generated by trans-splicing
Formerly held
Term ended
Term ended Dec 13, 2016 · From the USPTO record
Term endedTerm ended Dec 13, 2016From the USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited